United Therapeutics UTHR Unituxin — Cost of Sales

Other product segments

Similar metrics at other companies

WSCNew units — Cost of Sales

$6.22M-59.1%

CFUAN — Cost of Sales

$333M+1.5%

AVAVUxs — Cost of Goods Sold

$53.28M-14.7%

HUBBUtility Solutions — Cost of goods sold

$631.8M+7.9%

UGIUtilities — Cost of Sales

$461M+22.0%

UTIUTI — Total Operating Expenses

$138.53M+18.9%

Questions, answered.

What is United Therapeutics's unituxin — cost of sales?

United Therapeutics (UTHR) reported unituxin — cost of sales of $5M in Q1 2026.

How has United Therapeutics's unituxin — cost of sales changed year-over-year?

United Therapeutics's unituxin — cost of sales decreased by 3.8% year-over-year, from $5.2M to $5M.

What is the long-term trend for United Therapeutics's unituxin — cost of sales?

Over 4 years (2021 to 2025), United Therapeutics's unituxin — cost of sales has grown at a 5.4% compound annual growth rate (CAGR), from $14.2M to $17.5M.

What does unituxin — cost of sales mean?

This metric captures the direct costs associated with producing and delivering a specific pharmaceutical product to market. It includes manufacturing expenses, raw material costs, and direct distribution expenses related to the product line.